- Statement of Changes in Beneficial Ownership (4)
July 13 2010 - 11:52AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Expires:
February 28, 2011
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
CHAN LING SIU
|
2. Issuer Name
and
Ticker or Trading Symbol
China Biologic Products, Inc.
[
CBPO
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
__
X
__ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
NO. 14 EAST HUSHAN ROAD, TAI'AN CITY
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/11/2010
|
(Street)
SHANDONG, F4 271000
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Non-Qualified Stock Option
|
$12.26
|
7/11/2010
|
|
A
(1)
|
|
40000
|
|
10/11/2010
(1)
|
7/11/2010
|
Common Stock
|
40000
|
$0
|
190000
(2)
|
I
|
Spouse
|
Explanation of Responses:
|
(
1)
|
Represents ten year non-qualified stock options to purchase 40,000 shares of the Issuer's common stock, granted to Mr. Tung Lam, the Reporting Person's spouse, under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated July 11, 2010. The options will vest in equal portions on a quarterly basis over a 3-year period, with the first portion to vest on October 11, 2010.
|
(
2)
|
Includes previously reported ten year non-qualified stock options to purchase 50,000 shares of the Issuer's common stock at $4.00 per share, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated May 9, 2008, which vested immediately on the grant date, and ten year non-qualified stock options to purchase 100,000 shares of the Issuer's common stock at $4.00 per share, granted to the Reporting Person's spouse under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated May 9, 2008, which vested immediately on the grant date.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
CHAN LING SIU
NO. 14 EAST HUSHAN ROAD
TAI'AN CITY
SHANDONG, F4 271000
|
X
|
X
|
|
|
Signatures
|
/s/ Siu Ling Chan
|
|
7/13/2010
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jul 2023 to Jul 2024